Cito Capital Group, LLC Merck & Co., Inc. Transaction History
Cito Capital Group, LLC
- $244 Million
- Q1 2024
A detailed history of Cito Capital Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Cito Capital Group, LLC holds 23,256 shares of MRK stock, worth $2.93 Million. This represents 1.26% of its overall portfolio holdings.
Number of Shares
23,256
Previous 20,256
14.81%
Holding current value
$2.93 Million
Previous $2.22 Million
38.87%
% of portfolio
1.26%
Previous 0.95%
Shares
14 transactions
Others Institutions Holding MRK
# of Institutions
3,768Shares Held
1.87BCall Options Held
17.3MPut Options Held
14.8M-
Vanguard Group Inc Valley Forge, PA243MShares$30.6 Billion0.65% of portfolio
-
Black Rock Inc. New York, NY207MShares$26.1 Billion0.65% of portfolio
-
State Street Corp Boston, MA117MShares$14.8 Billion0.7% of portfolio
-
Wellington Management Group LLP Boston, MA86.3MShares$10.9 Billion2.07% of portfolio
-
Geode Capital Management, LLC Boston, MA56.4MShares$7.1 Billion0.7% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $319B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...